BLOG

Sunday, October 6, 2019

Glenmark Pharma slips 7% after US FDA issues warning letter for Baddi unit

The USFDA had inspected the company's Baddi facility between April 15 and April 20 and had earlier classified the inspection as an "Official Action Indicated".

from Home Page https://ift.tt/339KVkw
via IFTTT
at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Omicron has cast a shadow of uncertainty on growth outlook: IndiGo CEO

However, the airline is stronger now when compared to situation in 2020 during the first wave of the pandemic, says Ronojoy Dutta from Com...